Myelofibrosis and systemic lupus erythematosus. 1993

W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D055728 Primary Myelofibrosis A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. Agnogenic Myeloid Metaplasia,Bone Marrow Fibrosis,Chronic Idiopathic Myelofibrosis,Fibrosis, Bone Marrow,Idiopathic Myelofibrosis,Myelofibrosis,Myelofibrosis With Myeloid Metaplasia,Myeloid Metaplasia,Myelosclerosis,Myelosis, Nonleukemic,Agnogenic Myeloid Metaplasias,Bone Marrow Fibroses,Fibroses, Bone Marrow,Metaplasia, Agnogenic Myeloid,Metaplasia, Myeloid,Metaplasias, Agnogenic Myeloid,Metaplasias, Myeloid,Myelofibroses,Myelofibroses, Primary,Myelofibrosis, Primary,Myeloid Metaplasia, Agnogenic,Myeloid Metaplasias,Myeloid Metaplasias, Agnogenic,Myeloscleroses,Myeloses, Nonleukemic,Nonleukemic Myeloses,Nonleukemic Myelosis,Primary Myelofibroses

Related Publications

W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe
November 1986, The American journal of medicine,
W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe
September 1989, Clinical rheumatology,
W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe
November 2000, Leukemia & lymphoma,
W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe
August 1992, The Journal of rheumatology,
W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe
January 1998, Haematologia,
W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe
January 1988, Acta haematologica,
W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe
January 2024, European journal of case reports in internal medicine,
W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe
August 2023, BMJ case reports,
W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe
July 1995, Pathology,
W Hirose, and H Fukuya, and T Anzai, and M Kawagoe, and T Kawai, and K Watanabe
April 2000, European journal of internal medicine,
Copied contents to your clipboard!